深圳视见医疗科技有限公司

视见医疗是深圳视见医疗科技有限公司旗下品牌。深圳视见医疗科技有限公司是一家具有原创核心技术积累，以人工智能深度学习技术为驱动，专注医学影像智能化分析的初创企业。视见医疗科技的产品研发包括放射影像辅助诊断、放疗靶区勾勒及病理（细胞学、组织学）影像辅助诊断三大方向。核心团队来自香港中文大学、香港科技大学的教授和博士团队，在医学影像计算领域有深厚的技术积累，同时在视见医疗的研发团队中，有来自港中文、港科大、港大、澳洲国立、清华、北航、上交大等海内外顶尖学府的优秀人才，在医疗影像处理、深度学习算法、医学临床研究等方面拥有丰富的实践经验。在国内，公司已和北京协和医院、四川大学华西医院、中山大学附属肿瘤医院、上海同济医院等五十多家顶级三甲医院达成了战略合作。 公司目前已完成由深创投领投的1亿元A轮融资。目前公司在香港、深圳、北京和成都设立研发中心，诚聘优秀人才加入团队，携手打造智慧医疗的美好未来！ Imsight Medical Technology Co. Ltd. is a start-up company with the original core technology accumulation, driven by artificial intelligence deep learning technology, focus on medical imaging intelligent analysis. Currently, Imsight has three major products under development includes radiological imaging assisted diagnosis, radiotherapy target mapping and pathological (cytological, histological) imaging assisted diagnosis. The R&D leaders consist of professor and PhDs from CUHK and HKUST, who has plenty of experience in medical imaging computing field, Imsight R&D team is from CUHK, HKUST, HKU, ANU, Tsinghua University, Beihang, SJTU and other top universities from home and abroad. In the feild of medical imaging processing, Deep learning algorithms, medical clinical research and so on, Imsight R&D team have a lots of practical experience. Imsight has completed the 100 million-A-round financing from Shenzhen Venture investment.At present, Imsight set up R&D centres in Hong Kong, Shenzhen, Beijing and Chengdu, Imsight plans to recruit outstanding talent, and works together to create a bright future of Smart Medicalcare!